Walgreens Boots Alliance, Inc.NASDAQ
Wed, Nov. 16, 2:53 AM
- Theranos (Private:THERA) allegedly voided 11.3% of all blood-test reports that it provided to customers of Walgreens (NASDAQ:WBA) stores through a yearslong partnership between the two companies.
- When news broke last week that Walgreens had filed a $140M suit against Elizabeth Holmes' now-hobbled unicorn for breach of contact - details were sparse - but a public version of the complaint against Theranos has now been released.
Fri, Nov. 11, 4:57 PM
- Albertsons and Kroger (NYSE:KR) have emerged as key prospective suitors for Walgreens (NASDAQ:WBA) in its attempts to find a way to satisfy the FTC's review of the company's proposed acquisition of Rite Aid (NYSE:RAD), while CVS (NYSE:CVS) seems to have withdrawn interest, CTFN reports.
- Walgreens has not yet "freshened up the package" of store selloffs that it plans to present to the FTC, according to the report, which cites an antitrust attorney, who also says that "Albertsons and Kroger are established retail players with experience in pharmacies" and that the assets they are eyeing represent "key geographic expansion for both."
Tue, Nov. 8, 5:47 PM
- Walgreens Boots Alliance (NASDAQ:WBA) files a lawsuit against former lab tersting partner Theranos, alleging breach of contract and demanding a jury trial.
- WBA's Walgreens drug store unit is seeking $140M in damages, according to court records, which repreents the amount it invested in Theranos, Dow Jones reports.
- Walgreens alleges Theranos misled it about the state of its technology when the two firms initially forged their agreement, and perhaps continued to do so.
Fri, Oct. 28, 11:22 AM
- Drug wholesaler McKesson's (MCK -23.2%) lackluster Q3 numbers and softer guidance due to pricing pressure is weighing on the entire drug supply chain. Competitors AmerisourceBergen (ABC -11.9%) and Cardinal Health (CAH -11.2%) report next week.
- Representative tickers: (ESRX -4.5%)(CVS -3.9%)(WBA -2.7%)(RAD -0.9%)(UNH +0.1%)
Thu, Oct. 27, 2:41 PM
- Amazon (NASDAQ:AMZN) sees an opportunity in the U.S. to open up as many as 2K Amazon Fresh grocery stores in the next ten years, according to Business Insider.
- A 20-store pilot program is expected to be up and running by the end of 2018, with a mix of traditional-style grocery stores and online pickup locations.
- Internal documents reviewed by BI indicate that Amazon is still deciding if the stores will be tied to Amazon Prime memberships.
- Amazon's determination with a large-scale store roll-out could have significance for grocery stores and other retail chains (WMK, SVU, WFM, IMKTA, CASY, KR, SFS, WBA, CASY, WMT, TGT, RAD) as they consider their own future models.
- Retail ETFs: XLY, XRT, VCR, RTH, RETL, FXD, IYC, FDIS, SCC, RCD, UCC, PMR, CNDF, FTXD, JHMC.
Fri, Oct. 21, 7:46 AM
- Almost Family (NASDAQ:AFAM) upgraded to Outperform from Sector Perform with a $55 (31% upside) price target by RBC Capital.
- Walgreens Boots Alliance (NASDAQ:WBA) upgraded to Buy from Hold by Jefferies. Price target raised to $95 (17% upside) from $87.
- Arbutus Biopharma (NASDAQ:ABUS) upgraded to Neutral from Sell with a $3 price (0% upside) target by Chardan Capital.
- Quintiles IMS Holdings (NYSE:Q) downgraded to Hold from Buy with a $79 (6% upside) price target by Jefferies.
- Anthem (NYSE:ANTM) downgraded to Neutral from Overweight by JPMorgan. Price target lowered to $132 (6% upside) from $154.
- Bluebird bio (NASDAQ:BLUE) downgraded to Sell from Hold by Cantor Fitzgerald. Price target lowered to $37 (32% downside risk) from $42.
- Henry Schein (NASDAQ:HSIC) downgraded to Neutral from Buy by Baird. Price target lowered to $164 (7% upside) from $176.
Thu, Oct. 20, 8:44 AM
- Walgreens Boots Alliance (NASDAQ:WBA) fiscal Q4 results ($M): Net Sales: 28,636 (+0.4%); Retail Pharmacy USA: 20,747 (+4.0%); Retail Pharmacy Intl: 3,037 (-10.9%); Pharmaceutical Wholesale: 5,400 (-6.2%).
- Operating Income: 1,140 (+36.4%); Net Income: 1,035 (+999%); Non-GAAP Net Income: 1,166 (+20.3%); EPS: 0.95 (+999%); Non-GAAP EPS: 1.07 (+21.6%); CF Ops: 2,658 (+76.6%).
- Fiscal 2017 Guidance: Non-GAAP EPS: $4.85 - 5.20, including $0.05 - 0.12 accretion from Rite Aid.
- Shares are up 2% premarket on modest volume.
Thu, Oct. 20, 8:22 AM
Thu, Oct. 20, 7:08 AM| Thu, Oct. 20, 7:08 AM | 13 Comments
Thu, Oct. 20, 7:03 AM
Wed, Oct. 19, 5:30 PM
Wed, Oct. 19, 10:59 AM
- Just a negotiating tactic? Height Securities suggests that Kroger (KR +0.5%) may have intentionally leaked that they were close to stepping away from plans to buy Walgreens and Rite Aid (RAD -5.3%) stores.
- The investment firm speculates that Kroger is still in the mix while it waits for a sweeter offer from Walgreen Boots Alliance (WBA -0.8%).
- Previously: NY Post: Kroger may not buy Walgreens-Rite Aid stores (Oct. 19)
Wed, Oct. 19, 10:14 AM
- Rite Aid (RAD -4.5%) tumbles in early trading after the NY Post reports that Kroger (KR +0.3%) may pass on buying the 650 stores that Walgreens (WBA -1.2%) and RAD would need to sell to gain regulatory approval for their planned merger.
- KR may decide not to buy because the Federal Trade Commission, now a year into its merger review, recently told the company that the stores could not be purchased and closed, with the operations moved inside the grocery stores, according to the report.
- A WBA-RAD merger would create the biggest U.S. drug chain, and the FTC could sue to block the deal without a solution to the stores, but the report quotes a source as saying that both the FTC and WAG remain motivated to find a remedy.
Mon, Oct. 17, 12:22 PM
- Walgreens is the latest retailer to add ship-to-store capabilities to its e-commerce business.
- The chain says there will be no minimum charge for the Ship to Store program. Free shipping will still apply to online orders of $35 or more sent to a customer's home.
- Parent Walgreen Boots Alliance (WBA -0.3%) is due to report Q3 earnings on October 20.
Wed, Oct. 12, 4:31 PM
Tue, Oct. 11, 1:35 PM
- A large part of the retail sector will need to keep a watchful eye on Project Como at Amazon. The plan from the Seattle company to sell perishables out of small brick-and-mortar stores could be a disrupter if it were to be built out at scale.
- Convenience store chains such as Casey's General Stores (NASDAQ:CASY), Murphy's USA (NYSE:MUSA), and CST Brands (NYSE:CST) are already being targeted by 7-Eleven's aggressive expansion goals in the U.S. A store roll-out by Amazon could also impact drug store chains Walgreens (NASDAQ:WBA) and Rite Aid (NYSE:RAD) - as well as apply pricing pressure to the sensitive grocery store sector (KR, SVU, SPTN, IMKTA).
- Previously: 7-Eleven eyes huge expansion in U.S. (Sept. 22)
- Previously: Amazon considered to be planning convenience stores, curbside pickup locations for grocery products (Oct. 11)